NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and the risk of lung cancer: A meta‐analysis

Background:  NAD(P)H:quinine oxidoreductase 1 (NQO1) is a two‐electron reductase that catalyzes quinine to hydroquinone. Variant genotypes of NQO1 Pro187Ser may be related to low enzyme activity and thus are suggested as affecting the risk of lung cancer. Our purpose was to study the NQO1 Pro187Ser polymorphism and the risk of lung cancer.

[1]  Jenny Chang-Claude,et al.  Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early‐onset lung cancer , 2010, International journal of cancer.

[2]  D. Ross,et al.  NAD(P)H:quinone Oxidoreductase 1 (NQO1): Chemoprotection, Bioactivation, Gene Regulation and Genetic Polymorphisms , 2010 .

[3]  S. Land,et al.  Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. , 2009, Carcinogenesis.

[4]  Yun-Chul Hong,et al.  Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans , 2009, Cancer Causes & Control.

[5]  J. S. Lee,et al.  Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. , 2007, Lung cancer.

[6]  F. Clavel-Chapelon,et al.  Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Y. Kwong,et al.  Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. , 2005, Cancer genetics and cytogenetics.

[8]  Karla A. Lawson,et al.  Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C→T Polymorphism with Lung Cancer Risk among Male Smokers , 2005, Cancer Epidemiology Biomarkers & Prevention.

[9]  K. Overvad,et al.  Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. , 2005, Lung cancer.

[10]  A. Tjønneland,et al.  Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. , 2005, Cancer letters.

[11]  M. Spitz,et al.  An association between a NQO1 genetic polymorphism and risk of lung cancer. , 2005, Mutation research.

[12]  Nathaniel Rothman,et al.  Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. , 2004, Carcinogenesis.

[13]  S. Land,et al.  NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study. , 2004, Carcinogenesis.

[14]  L. Yin,et al.  [Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China]. , 2004, Yi chuan = Hereditas.

[15]  M. Warholm,et al.  Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Y. Hsueh,et al.  Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. , 2003, Lung cancer.

[17]  J. Yokota,et al.  Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  K. Matsuo,et al.  NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese , 2002, International Journal of Clinical Oncology.

[19]  Eula Bingham,et al.  NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review , 2002, Genetics in Medicine.

[20]  S. Lewis,et al.  Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. , 2001, Lung cancer.

[21]  L. Yin,et al.  Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. , 2001, Lung cancer.

[22]  D. Christiani,et al.  The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  D. Ross,et al.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. , 2000, Chemico-biological interactions.

[24]  L. Marchand,et al.  Association of the NAD(P)H:quinone oxidoreductase 609C-->T polymorphism with a decreased lung cancer risk. , 1999, Cancer research.

[25]  D. Ross,et al.  Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. , 1999, Pharmacogenetics.

[26]  M. Spitz,et al.  Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  B. Kuehl,et al.  A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. , 1996, British Journal of Cancer.

[28]  A. Jaiswal,et al.  NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Danenberg,et al.  NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. , 1992, Cancer research.

[30]  A. Jaiswal,et al.  Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin. , 1991, Biochemistry.

[31]  G. Powis,et al.  Cytosolic NAD(P)H:(Quinone‐acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol , 1990, International journal of cancer.

[32]  D W Nebert,et al.  Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. , 1988, The Journal of biological chemistry.

[33]  Yin Li.  A Study on Relationship between Susceptibility to Lung Cancer and Polymorphisms of NQO1,CYP1A1,mEH Genes , 2003 .